401k Plan data: SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN plan

SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 401k Plan overview

Plan Name	SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN
Plan identification number	001

SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN Benefits

401k Plan Type

Defined Contribution Pension

Plan Features/Benefits

Profit-sharing
ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.

401k Sponsoring company profile

SUNESIS PHARMACEUTICALS, INC. has sponsored the creation of one or more 401k plans.

Company Name: SUNESIS PHARMACEUTICALS, INC.

Employer identification number (EIN): 943295878

NAIC Classification: 541700

Form 5500 Filing Information

Submission information for form 5500 for 401k plan SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator Signed Name of Company Sponsor Date Sponsor Signed
001 2021-01-01
001 2020-01-01
001 2019-01-01
001 2018-01-01 TINA GULLOTTA
001 2017-01-01 ESTHER JHUN
001 2017-01-01 ESTHER JHUN
001 2016-01-01 ESTHER JHUN
001 2015-01-01 ESTHER JHUN
001 2014-01-01 DAVID TUCKER
001 2013-01-01 STEPHEN YEUNG
001 2012-01-01 DAVID TUCKER ERIC BJERKHOLT 2013-06-18
001 2011-01-01 DAVID TUCKER ERIC BJERKHOLT 2012-06-19
001 2009-01-01 DAVID TUCKER ERIC BJERKHOLT 2010-09-21

Plan id#	Filing Submission Date	Name of Administrator	Name of Company Sponsor	Date Sponsor Signed
001	2021-01-01
001	2020-01-01
001	2019-01-01
001	2018-01-01	TINA GULLOTTA
001	2017-01-01	ESTHER JHUN
001	2017-01-01	ESTHER JHUN
001	2016-01-01	ESTHER JHUN
001	2015-01-01	ESTHER JHUN
001	2014-01-01	DAVID TUCKER
001	2013-01-01	STEPHEN YEUNG
001	2012-01-01	DAVID TUCKER	ERIC BJERKHOLT	2013-06-18
001	2011-01-01	DAVID TUCKER	ERIC BJERKHOLT	2012-06-19
001	2009-01-01	DAVID TUCKER	ERIC BJERKHOLT	2010-09-21

Plan Statistics for SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN

401k plan membership statisitcs for SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN

Measure Date Value
2021: SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2021 401k membership
Total participants, beginning-of-year 2021-01-01 54
Total number of active participants reported on line 7a of the Form 5500 2021-01-01 0
Number of retired or separated participants receiving benefits 2021-01-01 0
Number of other retired or separated participants entitled to future benefits 2021-01-01 0
Total of all active and inactive participants 2021-01-01 0
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2021-01-01 0
Total participants 2021-01-01 0
Number of participants with account balances 2021-01-01 0
2020: SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2020 401k membership
Total participants, beginning-of-year 2020-01-01 68
Total number of active participants reported on line 7a of the Form 5500 2020-01-01 8
Number of retired or separated participants receiving benefits 2020-01-01 0
Number of other retired or separated participants entitled to future benefits 2020-01-01 46
Total of all active and inactive participants 2020-01-01 54
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2020-01-01 0
Total participants 2020-01-01 54
Number of participants with account balances 2020-01-01 53
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2020-01-01 0
2019: SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2019 401k membership
Total participants, beginning-of-year 2019-01-01 75
Total number of active participants reported on line 7a of the Form 5500 2019-01-01 27
Number of retired or separated participants receiving benefits 2019-01-01 0
Number of other retired or separated participants entitled to future benefits 2019-01-01 41
Total of all active and inactive participants 2019-01-01 68
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2019-01-01 0
Total participants 2019-01-01 68
Number of participants with account balances 2019-01-01 64
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2019-01-01 0
2018: SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2018 401k membership
Total participants, beginning-of-year 2018-01-01 80
Total number of active participants reported on line 7a of the Form 5500 2018-01-01 31
Number of retired or separated participants receiving benefits 2018-01-01 0
Number of other retired or separated participants entitled to future benefits 2018-01-01 44
Total of all active and inactive participants 2018-01-01 75
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2018-01-01 0
Total participants 2018-01-01 75
Number of participants with account balances 2018-01-01 72
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2018-01-01 0
2017: SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2017 401k membership
Total participants, beginning-of-year 2017-01-01 79
Total number of active participants reported on line 7a of the Form 5500 2017-01-01 38
Number of retired or separated participants receiving benefits 2017-01-01 0
Number of other retired or separated participants entitled to future benefits 2017-01-01 42
Total of all active and inactive participants 2017-01-01 80
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2017-01-01 0
Total participants 2017-01-01 80
Number of participants with account balances 2017-01-01 75
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2017-01-01 0
2016: SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2016 401k membership
Total participants, beginning-of-year 2016-01-01 76
Total number of active participants reported on line 7a of the Form 5500 2016-01-01 37
Number of retired or separated participants receiving benefits 2016-01-01 0
Number of other retired or separated participants entitled to future benefits 2016-01-01 42
Total of all active and inactive participants 2016-01-01 79
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2016-01-01 0
Total participants 2016-01-01 79
Number of participants with account balances 2016-01-01 70
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2016-01-01 0
2015: SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2015 401k membership
Total participants, beginning-of-year 2015-01-01 79
Total number of active participants reported on line 7a of the Form 5500 2015-01-01 38
Number of retired or separated participants receiving benefits 2015-01-01 0
Number of other retired or separated participants entitled to future benefits 2015-01-01 38
Total of all active and inactive participants 2015-01-01 76
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2015-01-01 0
Total participants 2015-01-01 76
Number of participants with account balances 2015-01-01 68
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2015-01-01 0
2014: SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2014 401k membership
Total participants, beginning-of-year 2014-01-01 74
Total number of active participants reported on line 7a of the Form 5500 2014-01-01 40
Number of retired or separated participants receiving benefits 2014-01-01 0
Number of other retired or separated participants entitled to future benefits 2014-01-01 39
Total of all active and inactive participants 2014-01-01 79
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2014-01-01 0
Total participants 2014-01-01 79
Number of participants with account balances 2014-01-01 73
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2014-01-01 0
2013: SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2013 401k membership
Total participants, beginning-of-year 2013-01-01 76
Total number of active participants reported on line 7a of the Form 5500 2013-01-01 31
Number of retired or separated participants receiving benefits 2013-01-01 0
Number of other retired or separated participants entitled to future benefits 2013-01-01 43
Total of all active and inactive participants 2013-01-01 74
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2013-01-01 0
Total participants 2013-01-01 74
Number of participants with account balances 2013-01-01 71
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2013-01-01 0
2012: SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2012 401k membership
Total participants, beginning-of-year 2012-01-01 86
Total number of active participants reported on line 7a of the Form 5500 2012-01-01 27
Number of retired or separated participants receiving benefits 2012-01-01 0
Number of other retired or separated participants entitled to future benefits 2012-01-01 49
Total of all active and inactive participants 2012-01-01 76
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2012-01-01 0
Total participants 2012-01-01 76
Number of participants with account balances 2012-01-01 73
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2012-01-01 0
2011: SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2011 401k membership
Total participants, beginning-of-year 2011-01-01 89
Total number of active participants reported on line 7a of the Form 5500 2011-01-01 31
Number of retired or separated participants receiving benefits 2011-01-01 0
Number of other retired or separated participants entitled to future benefits 2011-01-01 55
Total of all active and inactive participants 2011-01-01 86
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2011-01-01 0
Total participants 2011-01-01 86
Number of participants with account balances 2011-01-01 81
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2011-01-01 0
2009: SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2009 401k membership
Total participants, beginning-of-year 2009-01-01 132
Total number of active participants reported on line 7a of the Form 5500 2009-01-01 28
Number of retired or separated participants receiving benefits 2009-01-01 0
Number of other retired or separated participants entitled to future benefits 2009-01-01 68
Total of all active and inactive participants 2009-01-01 96
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2009-01-01 0
Total participants 2009-01-01 96
Number of participants with account balances 2009-01-01 94
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2009-01-01 0

Measure	Date	Value
2021: SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2021 401k membership
Total participants, beginning-of-year	2021-01-01	54
Total number of active participants reported on line 7a of the Form 5500	2021-01-01	0
Number of retired or separated participants receiving benefits	2021-01-01	0
Number of other retired or separated participants entitled to future benefits	2021-01-01	0
Total of all active and inactive participants	2021-01-01	0
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2021-01-01	0
Total participants	2021-01-01	0
Number of participants with account balances	2021-01-01	0
2020: SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2020 401k membership
Total participants, beginning-of-year	2020-01-01	68
Total number of active participants reported on line 7a of the Form 5500	2020-01-01	8
Number of retired or separated participants receiving benefits	2020-01-01	0
Number of other retired or separated participants entitled to future benefits	2020-01-01	46
Total of all active and inactive participants	2020-01-01	54
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2020-01-01	0
Total participants	2020-01-01	54
Number of participants with account balances	2020-01-01	53
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2020-01-01	0
2019: SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2019 401k membership
Total participants, beginning-of-year	2019-01-01	75
Total number of active participants reported on line 7a of the Form 5500	2019-01-01	27
Number of retired or separated participants receiving benefits	2019-01-01	0
Number of other retired or separated participants entitled to future benefits	2019-01-01	41
Total of all active and inactive participants	2019-01-01	68
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2019-01-01	0
Total participants	2019-01-01	68
Number of participants with account balances	2019-01-01	64
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2019-01-01	0
2018: SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2018 401k membership
Total participants, beginning-of-year	2018-01-01	80
Total number of active participants reported on line 7a of the Form 5500	2018-01-01	31
Number of retired or separated participants receiving benefits	2018-01-01	0
Number of other retired or separated participants entitled to future benefits	2018-01-01	44
Total of all active and inactive participants	2018-01-01	75
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2018-01-01	0
Total participants	2018-01-01	75
Number of participants with account balances	2018-01-01	72
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2018-01-01	0
2017: SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2017 401k membership
Total participants, beginning-of-year	2017-01-01	79
Total number of active participants reported on line 7a of the Form 5500	2017-01-01	38
Number of retired or separated participants receiving benefits	2017-01-01	0
Number of other retired or separated participants entitled to future benefits	2017-01-01	42
Total of all active and inactive participants	2017-01-01	80
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2017-01-01	0
Total participants	2017-01-01	80
Number of participants with account balances	2017-01-01	75
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2017-01-01	0
2016: SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2016 401k membership
Total participants, beginning-of-year	2016-01-01	76
Total number of active participants reported on line 7a of the Form 5500	2016-01-01	37
Number of retired or separated participants receiving benefits	2016-01-01	0
Number of other retired or separated participants entitled to future benefits	2016-01-01	42
Total of all active and inactive participants	2016-01-01	79
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2016-01-01	0
Total participants	2016-01-01	79
Number of participants with account balances	2016-01-01	70
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2016-01-01	0
2015: SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2015 401k membership
Total participants, beginning-of-year	2015-01-01	79
Total number of active participants reported on line 7a of the Form 5500	2015-01-01	38
Number of retired or separated participants receiving benefits	2015-01-01	0
Number of other retired or separated participants entitled to future benefits	2015-01-01	38
Total of all active and inactive participants	2015-01-01	76
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2015-01-01	0
Total participants	2015-01-01	76
Number of participants with account balances	2015-01-01	68
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2015-01-01	0
2014: SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2014 401k membership
Total participants, beginning-of-year	2014-01-01	74
Total number of active participants reported on line 7a of the Form 5500	2014-01-01	40
Number of retired or separated participants receiving benefits	2014-01-01	0
Number of other retired or separated participants entitled to future benefits	2014-01-01	39
Total of all active and inactive participants	2014-01-01	79
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2014-01-01	0
Total participants	2014-01-01	79
Number of participants with account balances	2014-01-01	73
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2014-01-01	0
2013: SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2013 401k membership
Total participants, beginning-of-year	2013-01-01	76
Total number of active participants reported on line 7a of the Form 5500	2013-01-01	31
Number of retired or separated participants receiving benefits	2013-01-01	0
Number of other retired or separated participants entitled to future benefits	2013-01-01	43
Total of all active and inactive participants	2013-01-01	74
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2013-01-01	0
Total participants	2013-01-01	74
Number of participants with account balances	2013-01-01	71
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2013-01-01	0
2012: SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2012 401k membership
Total participants, beginning-of-year	2012-01-01	86
Total number of active participants reported on line 7a of the Form 5500	2012-01-01	27
Number of retired or separated participants receiving benefits	2012-01-01	0
Number of other retired or separated participants entitled to future benefits	2012-01-01	49
Total of all active and inactive participants	2012-01-01	76
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2012-01-01	0
Total participants	2012-01-01	76
Number of participants with account balances	2012-01-01	73
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2012-01-01	0
2011: SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2011 401k membership
Total participants, beginning-of-year	2011-01-01	89
Total number of active participants reported on line 7a of the Form 5500	2011-01-01	31
Number of retired or separated participants receiving benefits	2011-01-01	0
Number of other retired or separated participants entitled to future benefits	2011-01-01	55
Total of all active and inactive participants	2011-01-01	86
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2011-01-01	0
Total participants	2011-01-01	86
Number of participants with account balances	2011-01-01	81
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2011-01-01	0
2009: SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2009 401k membership
Total participants, beginning-of-year	2009-01-01	132
Total number of active participants reported on line 7a of the Form 5500	2009-01-01	28
Number of retired or separated participants receiving benefits	2009-01-01	0
Number of other retired or separated participants entitled to future benefits	2009-01-01	68
Total of all active and inactive participants	2009-01-01	96
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2009-01-01	0
Total participants	2009-01-01	96
Number of participants with account balances	2009-01-01	94
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2009-01-01	0

Financial Data on SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN

Measure	Date	Value
2021 : SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2021 401k financial data
Transfers to/from the plan	2021-12-21	$0
Total plan liabilities at end of year	2021-12-21	$0
Total plan liabilities at beginning of year	2021-12-21	$0
Total income from all sources	2021-12-21	$1,676,781
Expenses. Total of all expenses incurred	2021-12-21	$11,756,564
Benefits paid (including direct rollovers)	2021-12-21	$11,754,269
Total plan assets at end of year	2021-12-21	$0
Total plan assets at beginning of year	2021-12-21	$10,079,783
Value of fidelity bond covering the plan	2021-12-21	$500,000
Total contributions received or receivable from participants	2021-12-21	$133,409
Expenses. Other expenses not covered elsewhere	2021-12-21	$0
Contributions received from other sources (not participants or employers)	2021-12-21	$0
Other income received	2021-12-21	$1,543,155
Noncash contributions received	2021-12-21	$0
Net income (gross income less expenses)	2021-12-21	$-10,079,783
Net plan assets at end of year (total assets less liabilities)	2021-12-21	$0
Net plan assets at beginning of year (total assets less liabilities)	2021-12-21	$10,079,783
Total contributions received or receivable from employer(s)	2021-12-21	$217
Value of certain deemed distributions of participant loans	2021-12-21	$0
Value of corrective distributions	2021-12-21	$0
Expenses. Administrative service providers (salaries,fees and commissions)	2021-12-21	$2,295
2020 : SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2020 401k financial data
Transfers to/from the plan	2020-12-31	$0
Total plan liabilities at end of year	2020-12-31	$0
Total plan liabilities at beginning of year	2020-12-31	$0
Total income from all sources	2020-12-31	$2,096,400
Expenses. Total of all expenses incurred	2020-12-31	$2,454,198
Benefits paid (including direct rollovers)	2020-12-31	$2,451,760
Total plan assets at end of year	2020-12-31	$10,079,783
Total plan assets at beginning of year	2020-12-31	$10,437,581
Value of fidelity bond covering the plan	2020-12-31	$500,000
Assets. Value of tangible personal property	2020-12-31	$0
Total contributions received or receivable from participants	2020-12-31	$414,589
Assets. Value of loans (other than to participants)	2020-12-31	$0
Expenses. Other expenses not covered elsewhere	2020-12-31	$0
Contributions received from other sources (not participants or employers)	2020-12-31	$0
Other income received	2020-12-31	$1,664,311
Noncash contributions received	2020-12-31	$0
Net income (gross income less expenses)	2020-12-31	$-357,798
Net plan assets at end of year (total assets less liabilities)	2020-12-31	$10,079,783
Net plan assets at beginning of year (total assets less liabilities)	2020-12-31	$10,437,581
Assets. Value of participant loans	2020-12-31	$0
Assets. Value of assets in partnership/joint-venture interests	2020-12-31	$0
Assets. Value of real-estate (other than employer real property)	2020-12-31	$0
Assets. Value of employer securities	2020-12-31	$0
Assets. Value of employer real property	2020-12-31	$0
Total contributions received or receivable from employer(s)	2020-12-31	$17,500
Value of certain deemed distributions of participant loans	2020-12-31	$0
Value of corrective distributions	2020-12-31	$0
Expenses. Administrative service providers (salaries,fees and commissions)	2020-12-31	$2,438
2019 : SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2019 401k financial data
Transfers to/from the plan	2019-12-31	$0
Total plan liabilities at end of year	2019-12-31	$0
Total plan liabilities at beginning of year	2019-12-31	$0
Total income from all sources	2019-12-31	$2,627,563
Expenses. Total of all expenses incurred	2019-12-31	$688,087
Benefits paid (including direct rollovers)	2019-12-31	$686,211
Total plan assets at end of year	2019-12-31	$10,437,581
Total plan assets at beginning of year	2019-12-31	$8,498,105
Value of fidelity bond covering the plan	2019-12-31	$500,000
Total contributions received or receivable from participants	2019-12-31	$487,257
Expenses. Other expenses not covered elsewhere	2019-12-31	$0
Contributions received from other sources (not participants or employers)	2019-12-31	$0
Other income received	2019-12-31	$2,083,306
Noncash contributions received	2019-12-31	$0
Net income (gross income less expenses)	2019-12-31	$1,939,476
Net plan assets at end of year (total assets less liabilities)	2019-12-31	$10,437,581
Net plan assets at beginning of year (total assets less liabilities)	2019-12-31	$8,498,105
Assets. Value of participant loans	2019-12-31	$3,183
Total contributions received or receivable from employer(s)	2019-12-31	$57,000
Value of certain deemed distributions of participant loans	2019-12-31	$0
Value of corrective distributions	2019-12-31	$0
Expenses. Administrative service providers (salaries,fees and commissions)	2019-12-31	$1,876
2018 : SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2018 401k financial data
Transfers to/from the plan	2018-12-31	$0
Total plan liabilities at end of year	2018-12-31	$0
Total plan liabilities at beginning of year	2018-12-31	$0
Total income from all sources	2018-12-31	$46,781
Expenses. Total of all expenses incurred	2018-12-31	$1,484,298
Benefits paid (including direct rollovers)	2018-12-31	$1,482,478
Total plan assets at end of year	2018-12-31	$8,498,105
Total plan assets at beginning of year	2018-12-31	$9,935,622
Value of fidelity bond covering the plan	2018-12-31	$500,000
Total contributions received or receivable from participants	2018-12-31	$544,758
Expenses. Other expenses not covered elsewhere	2018-12-31	$0
Contributions received from other sources (not participants or employers)	2018-12-31	$0
Other income received	2018-12-31	$-567,309
Noncash contributions received	2018-12-31	$0
Net income (gross income less expenses)	2018-12-31	$-1,437,517
Net plan assets at end of year (total assets less liabilities)	2018-12-31	$8,498,105
Net plan assets at beginning of year (total assets less liabilities)	2018-12-31	$9,935,622
Assets. Value of participant loans	2018-12-31	$5,055
Total contributions received or receivable from employer(s)	2018-12-31	$69,332
Value of certain deemed distributions of participant loans	2018-12-31	$0
Value of corrective distributions	2018-12-31	$0
Expenses. Administrative service providers (salaries,fees and commissions)	2018-12-31	$1,820
2017 : SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2017 401k financial data
Transfers to/from the plan	2017-12-31	$0
Total plan liabilities at end of year	2017-12-31	$0
Total plan liabilities at beginning of year	2017-12-31	$0
Total income from all sources	2017-12-31	$2,197,095
Expenses. Total of all expenses incurred	2017-12-31	$950,068
Benefits paid (including direct rollovers)	2017-12-31	$948,700
Total plan assets at end of year	2017-12-31	$9,935,622
Total plan assets at beginning of year	2017-12-31	$8,688,595
Value of fidelity bond covering the plan	2017-12-31	$500,000
Assets. Value of tangible personal property	2017-12-31	$0
Total contributions received or receivable from participants	2017-12-31	$569,501
Assets. Value of loans (other than to participants)	2017-12-31	$0
Expenses. Other expenses not covered elsewhere	2017-12-31	$0
Contributions received from other sources (not participants or employers)	2017-12-31	$0
Other income received	2017-12-31	$1,548,515
Noncash contributions received	2017-12-31	$0
Net income (gross income less expenses)	2017-12-31	$1,247,027
Net plan assets at end of year (total assets less liabilities)	2017-12-31	$9,935,622
Net plan assets at beginning of year (total assets less liabilities)	2017-12-31	$8,688,595
Assets. Value of participant loans	2017-12-31	$9,936
Assets. Value of assets in partnership/joint-venture interests	2017-12-31	$0
Assets. Value of real-estate (other than employer real property)	2017-12-31	$0
Assets. Value of employer securities	2017-12-31	$0
Assets. Value of employer real property	2017-12-31	$0
Total contributions received or receivable from employer(s)	2017-12-31	$79,079
Value of certain deemed distributions of participant loans	2017-12-31	$0
Value of corrective distributions	2017-12-31	$0
Expenses. Administrative service providers (salaries,fees and commissions)	2017-12-31	$1,368
2016 : SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2016 401k financial data
Transfers to/from the plan	2016-12-31	$0
Total plan liabilities at end of year	2016-12-31	$0
Total plan liabilities at beginning of year	2016-12-31	$0
Total income from all sources	2016-12-31	$1,247,208
Expenses. Total of all expenses incurred	2016-12-31	$497,597
Benefits paid (including direct rollovers)	2016-12-31	$496,753
Total plan assets at end of year	2016-12-31	$8,688,595
Total plan assets at beginning of year	2016-12-31	$7,938,984
Value of fidelity bond covering the plan	2016-12-31	$500,000
Total contributions received or receivable from participants	2016-12-31	$563,258
Expenses. Other expenses not covered elsewhere	2016-12-31	$0
Contributions received from other sources (not participants or employers)	2016-12-31	$380
Other income received	2016-12-31	$614,033
Noncash contributions received	2016-12-31	$0
Net income (gross income less expenses)	2016-12-31	$749,611
Net plan assets at end of year (total assets less liabilities)	2016-12-31	$8,688,595
Net plan assets at beginning of year (total assets less liabilities)	2016-12-31	$7,938,984
Assets. Value of participant loans	2016-12-31	$23,546
Total contributions received or receivable from employer(s)	2016-12-31	$69,537
Value of certain deemed distributions of participant loans	2016-12-31	$0
Value of corrective distributions	2016-12-31	$0
Expenses. Administrative service providers (salaries,fees and commissions)	2016-12-31	$844
2015 : SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2015 401k financial data
Transfers to/from the plan	2015-12-31	$0
Total plan liabilities at end of year	2015-12-31	$0
Total plan liabilities at beginning of year	2015-12-31	$0
Total income from all sources	2015-12-31	$713,635
Expenses. Total of all expenses incurred	2015-12-31	$383,050
Benefits paid (including direct rollovers)	2015-12-31	$382,728
Total plan assets at end of year	2015-12-31	$7,938,984
Total plan assets at beginning of year	2015-12-31	$7,608,399
Value of fidelity bond covering the plan	2015-12-31	$500,000
Total contributions received or receivable from participants	2015-12-31	$586,271
Expenses. Other expenses not covered elsewhere	2015-12-31	$0
Contributions received from other sources (not participants or employers)	2015-12-31	$0
Other income received	2015-12-31	$47,364
Noncash contributions received	2015-12-31	$0
Net income (gross income less expenses)	2015-12-31	$330,585
Net plan assets at end of year (total assets less liabilities)	2015-12-31	$7,938,984
Net plan assets at beginning of year (total assets less liabilities)	2015-12-31	$7,608,399
Assets. Value of participant loans	2015-12-31	$30,090
Total contributions received or receivable from employer(s)	2015-12-31	$80,000
Value of certain deemed distributions of participant loans	2015-12-31	$0
Value of corrective distributions	2015-12-31	$0
Expenses. Administrative service providers (salaries,fees and commissions)	2015-12-31	$322
2014 : SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2014 401k financial data
Transfers to/from the plan	2014-12-31	$0
Total plan liabilities at end of year	2014-12-31	$0
Total plan liabilities at beginning of year	2014-12-31	$0
Total income from all sources	2014-12-31	$1,179,037
Expenses. Total of all expenses incurred	2014-12-31	$646,657
Benefits paid (including direct rollovers)	2014-12-31	$643,549
Total plan assets at end of year	2014-12-31	$7,608,399
Total plan assets at beginning of year	2014-12-31	$7,076,019
Value of fidelity bond covering the plan	2014-12-31	$500,000
Total contributions received or receivable from participants	2014-12-31	$551,990
Expenses. Other expenses not covered elsewhere	2014-12-31	$0
Contributions received from other sources (not participants or employers)	2014-12-31	$0
Other income received	2014-12-31	$542,047
Noncash contributions received	2014-12-31	$0
Net income (gross income less expenses)	2014-12-31	$532,380
Net plan assets at end of year (total assets less liabilities)	2014-12-31	$7,608,399
Net plan assets at beginning of year (total assets less liabilities)	2014-12-31	$7,076,019
Assets. Value of participant loans	2014-12-31	$40,565
Total contributions received or receivable from employer(s)	2014-12-31	$85,000
Value of certain deemed distributions of participant loans	2014-12-31	$0
Value of corrective distributions	2014-12-31	$2,905
Expenses. Administrative service providers (salaries,fees and commissions)	2014-12-31	$203
2013 : SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2013 401k financial data
Transfers to/from the plan	2013-12-31	$0
Total plan liabilities at end of year	2013-12-31	$0
Total income from all sources	2013-12-31	$2,382,457
Expenses. Total of all expenses incurred	2013-12-31	$849,281
Benefits paid (including direct rollovers)	2013-12-31	$849,100
Total plan assets at end of year	2013-12-31	$7,076,019
Total plan assets at beginning of year	2013-12-31	$5,542,843
Value of fidelity bond covering the plan	2013-12-31	$500,000
Total contributions received or receivable from participants	2013-12-31	$487,949
Expenses. Other expenses not covered elsewhere	2013-12-31	$0
Contributions received from other sources (not participants or employers)	2013-12-31	$531,300
Other income received	2013-12-31	$1,293,208
Noncash contributions received	2013-12-31	$0
Net income (gross income less expenses)	2013-12-31	$1,533,176
Net plan assets at end of year (total assets less liabilities)	2013-12-31	$7,076,019
Net plan assets at beginning of year (total assets less liabilities)	2013-12-31	$5,542,843
Assets. Value of participant loans	2013-12-31	$33,197
Total contributions received or receivable from employer(s)	2013-12-31	$70,000
Value of certain deemed distributions of participant loans	2013-12-31	$0
Value of corrective distributions	2013-12-31	$0
Expenses. Administrative service providers (salaries,fees and commissions)	2013-12-31	$181
2012 : SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2012 401k financial data
Total income from all sources	2012-12-31	$1,247,248
Expenses. Total of all expenses incurred	2012-12-31	$661,497
Benefits paid (including direct rollovers)	2012-12-31	$661,437
Total plan assets at end of year	2012-12-31	$5,542,843
Total plan assets at beginning of year	2012-12-31	$4,957,092
Value of fidelity bond covering the plan	2012-12-31	$500,000
Total contributions received or receivable from participants	2012-12-31	$463,123
Other income received	2012-12-31	$724,125
Net income (gross income less expenses)	2012-12-31	$585,751
Net plan assets at end of year (total assets less liabilities)	2012-12-31	$5,542,843
Net plan assets at beginning of year (total assets less liabilities)	2012-12-31	$4,957,092
Assets. Value of participant loans	2012-12-31	$2,997
Total contributions received or receivable from employer(s)	2012-12-31	$60,000
Expenses. Administrative service providers (salaries,fees and commissions)	2012-12-31	$60
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2012-12-31	$0
2011 : SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2011 401k financial data
Total income from all sources	2011-12-31	$332,410
Expenses. Total of all expenses incurred	2011-12-31	$434,006
Benefits paid (including direct rollovers)	2011-12-31	$433,973
Total plan assets at end of year	2011-12-31	$4,957,092
Total plan assets at beginning of year	2011-12-31	$5,058,688
Value of fidelity bond covering the plan	2011-12-31	$500,000
Total contributions received or receivable from participants	2011-12-31	$401,773
Other income received	2011-12-31	$-132,350
Net income (gross income less expenses)	2011-12-31	$-101,596
Net plan assets at end of year (total assets less liabilities)	2011-12-31	$4,957,092
Net plan assets at beginning of year (total assets less liabilities)	2011-12-31	$5,058,688
Assets. Value of participant loans	2011-12-31	$9,787
Total contributions received or receivable from employer(s)	2011-12-31	$62,987
Expenses. Administrative service providers (salaries,fees and commissions)	2011-12-31	$33
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2011-12-31	$0
2010 : SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2010 401k financial data
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2010-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2010-12-31	$0
Total income from all sources (including contributions)	2010-12-31	$1,074,344
Total of all expenses incurred	2010-12-31	$692,457
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2010-12-31	$687,177
Value of total corrective distributions	2010-12-31	$2,771
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2010-12-31	$435,791
Value of total assets at end of year	2010-12-31	$5,058,688
Value of total assets at beginning of year	2010-12-31	$4,676,801
Total of administrative expenses incurred including professional, contract, advisory and management fees	2010-12-31	$2,509
Total interest from all sources	2010-12-31	$1,613
Total dividends received (eg from common stock, registered investment company shares)	2010-12-31	$71,493
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2010-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2010-12-31	$71,493
Was this plan covered by a fidelity bond	2010-12-31	Yes
Value of fidelity bond cover	2010-12-31	$500,000
If this is an individual account plan, was there a blackout period	2010-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2010-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2010-12-31	No
Contributions received from participants	2010-12-31	$382,821
Participant contributions at end of year	2010-12-31	$16,040
Participant contributions at beginning of year	2010-12-31	$21,799
Administrative expenses (other) incurred	2010-12-31	$2,509
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2010-12-31	No
Value of net income/loss	2010-12-31	$381,887
Value of net assets at end of year (total assets less liabilities)	2010-12-31	$5,058,688
Value of net assets at beginning of year (total assets less liabilities)	2010-12-31	$4,676,801
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2010-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2010-12-31	No
Were any leases to which the plan was party in default or uncollectible	2010-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2010-12-31	$4,765,085
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2010-12-31	$4,325,203
Interest on participant loans	2010-12-31	$1,574
Value of interest in common/collective trusts at end of year	2010-12-31	$83,280
Value of interest in common/collective trusts at beginning of year	2010-12-31	$80,415
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2010-12-31	$194,283
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2010-12-31	$249,384
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2010-12-31	$249,384
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2010-12-31	$39
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2010-12-31	$561,830
Net investment gain or loss from common/collective trusts	2010-12-31	$3,617
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2010-12-31	No
Was there a failure to transmit to the plan any participant contributions	2010-12-31	No
Has the plan failed to provide any benefit when due under the plan	2010-12-31	No
Contributions received in cash from employer	2010-12-31	$52,970
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2010-12-31	$687,177
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2010-12-31	No
Did the plan have assets held for investment	2010-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2010-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2010-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2010-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2010-12-31	Disclaimer
Accountancy firm name	2010-12-31	FRANK, RIMERMAN CO., LLP
Accountancy firm EIN	2010-12-31	941341042
2009 : SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2009 401k financial data
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2009-12-31	$0

Form 5500 Responses for SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN

2021: SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2021 form 5500 responses
2021-01-01	Type of plan entity	Single employer plan
2021-01-01	Submission has been amended	No
2021-01-01	This submission is the final filing	Yes
2021-01-01	This return/report is a short plan year return/report (less than 12 months)	Yes
2021-01-01	Plan is a collectively bargained plan	No
2021-01-01	Plan funding arrangement – Trust	Yes
2021-01-01	Plan benefit arrangement - Trust	Yes
2020: SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2020 form 5500 responses
2020-01-01	Type of plan entity	Single employer plan
2020-01-01	This submission is the final filing	No
2020-01-01	Plan is a collectively bargained plan	No
2020-01-01	Plan funding arrangement – Trust	Yes
2020-01-01	Plan benefit arrangement - Trust	Yes
2019: SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2019 form 5500 responses
2019-01-01	Type of plan entity	Single employer plan
2019-01-01	Submission has been amended	No
2019-01-01	This submission is the final filing	No
2019-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2019-01-01	Plan is a collectively bargained plan	No
2019-01-01	Plan funding arrangement – Trust	Yes
2019-01-01	Plan benefit arrangement - Trust	Yes
2018: SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2018 form 5500 responses
2018-01-01	Type of plan entity	Single employer plan
2018-01-01	Submission has been amended	No
2018-01-01	This submission is the final filing	No
2018-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2018-01-01	Plan is a collectively bargained plan	No
2018-01-01	Plan funding arrangement – Trust	Yes
2018-01-01	Plan benefit arrangement - Trust	Yes
2017: SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2017 form 5500 responses
2017-01-01	Type of plan entity	Single employer plan
2017-01-01	Submission has been amended	No
2017-01-01	This submission is the final filing	No
2017-01-01	Plan is a collectively bargained plan	No
2017-01-01	Plan funding arrangement – Trust	Yes
2017-01-01	Plan benefit arrangement - Trust	Yes
2016: SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2016 form 5500 responses
2016-01-01	Type of plan entity	Single employer plan
2016-01-01	Submission has been amended	No
2016-01-01	This submission is the final filing	No
2016-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2016-01-01	Plan is a collectively bargained plan	No
2016-01-01	Plan funding arrangement – Trust	Yes
2016-01-01	Plan benefit arrangement - Trust	Yes
2015: SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2015 form 5500 responses
2015-01-01	Type of plan entity	Single employer plan
2015-01-01	Submission has been amended	No
2015-01-01	This submission is the final filing	No
2015-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2015-01-01	Plan is a collectively bargained plan	No
2015-01-01	Plan funding arrangement – Trust	Yes
2015-01-01	Plan benefit arrangement - Trust	Yes
2014: SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2014 form 5500 responses
2014-01-01	Type of plan entity	Single employer plan
2014-01-01	Submission has been amended	No
2014-01-01	This submission is the final filing	No
2014-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2014-01-01	Plan is a collectively bargained plan	No
2014-01-01	Plan funding arrangement – Trust	Yes
2014-01-01	Plan benefit arrangement - Trust	Yes
2013: SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2013 form 5500 responses
2013-01-01	Type of plan entity	Single employer plan
2013-01-01	Submission has been amended	No
2013-01-01	This submission is the final filing	No
2013-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2013-01-01	Plan is a collectively bargained plan	No
2013-01-01	Plan funding arrangement – Trust	Yes
2013-01-01	Plan benefit arrangement - Trust	Yes
2012: SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2012 form 5500 responses
2012-01-01	Type of plan entity	Single employer plan
2012-01-01	Submission has been amended	No
2012-01-01	This submission is the final filing	No
2012-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2012-01-01	Plan funding arrangement – Trust	Yes
2012-01-01	Plan benefit arrangement - Trust	Yes
2011: SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2011 form 5500 responses
2011-01-01	Type of plan entity	Single employer plan
2011-01-01	Submission has been amended	Yes
2011-01-01	This submission is the final filing	No
2011-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2011-01-01	Plan funding arrangement – Trust	Yes
2011-01-01	Plan benefit arrangement - Trust	Yes
2009: SUNESIS PHARMACEUTICALS, INC. 401(K) PLAN 2009 form 5500 responses
2009-01-01	Type of plan entity	Single employer plan
2009-01-01	Submission has been amended	No
2009-01-01	This submission is the final filing	No
2009-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2009-01-01	Plan funding arrangement – Trust	Yes
2009-01-01	Plan benefit arrangement - Trust	Yes

Was this data useful?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer

The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Company Name:	SUNESIS PHARMACEUTICALS, INC.
Employer identification number (EIN):	943295878
NAIC Classification:	541700